Suven Life Sciences Limited
Suven Life Sciences Limited
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Active, not recruiting | Phase 3 | 2026-09-15 | NCT05397639 | |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE) | Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, Sleep Disorders, Intrinsic, narcolepsy, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Phase 3 | 2026-09-03 | NCT07540364 |